Skip to content
everlon

Learn

Guides, without the sales pitch

What things cost, how provider-guided telehealth works, and what to check before you start — written to be useful whether or not you ever use Everlon.

How much does semaglutide cost without insurance? (2026 guide)

What compounded semaglutide costs at Everlon: $179 for your first 4-week supply, then $249 every 4 weeks, at every dose, if prescribed.

Tirzepatide cost without insurance in 2026

Tirzepatide cost without insurance in 2026, and what is included. At Everlon: $229 for your first 4-week supply, then $299 every 4 weeks, if prescribed.

How to check an online GLP-1 provider is legitimate

How to check an online GLP-1 provider before you pay: LegitScript, the pharmacy's state license, the prescriber's license, and the red flags.

Medicare's GLP-1 Bridge, explained

When Medicare Part D pays for GLP-1s, why weight loss alone isn't covered, and how the 2026 Bridge works: who qualifies, the $50 copay and the dates.

NAD+ nasal spray: what it is, how it works and what it costs

NAD+ nasal spray is a needle-free way to take NAD+ at home. What it is, how an online provider prescribes it, what it costs and what to expect.

NAD+ injections at home: how they work and what they cost

NAD+ injections let you skip the IV clinic. How an online provider prescribes them, what's included, what they cost and what to expect.

What LegitScript certification means, and what it doesn't

LegitScript certifies online pharmacies and telehealth companies. What it checks, why ad platforms ask for it, what it doesn't mean, and how to check.

How a 503A compounding pharmacy works

What a 503A compounding pharmacy is, the federal rules it works under, how it differs from a 503B outsourcing facility, and what compounded means for you.

HHS's 2026 draft peptide compounding policy, explained

HHS's draft policy, open for comment, says it won't act against compounding six peptides under strict conditions. Routes, conditions, limits.

The July 2026 FDA peptide vote, explained

News reports say FDA's compounding committee backed six of seven peptides in July 2026. What the vote did, HHS's draft policy, and where each stands.

What is the KPV peptide? The research and its FDA status

KPV is a three-amino-acid piece of alpha-MSH. What has been studied, what FDA reviewed, and what HHS's 2026 draft policy would cover: topical and oral.

BPC-157 vs TB-500: what each is, what's been studied, and FDA status

BPC-157 and TB-500: unrelated peptides with thin human research. Their FDA status, HHS's 2026 draft peptide policy, and the 'Wolverine stack' term.

Is BPC-157 legal or FDA approved? (2026 status)

BPC-157 is still not FDA-approved. What HHS's October 2026 draft policy would cover for it: routes, conditions, and what it does not change.

What is Semax? The research and its FDA status

Semax is a lab-made peptide based on an ACTH fragment. Is it FDA approved, and what does HHS's October 2026 draft policy cover? Intranasal only.

What is TB-500? Thymosin beta-4, the research and FDA status

TB-500 is a synthetic fragment of thymosin beta-4. What has been studied, what FDA says, and what HHS's 2026 draft policy would cover: injection only.

What is MOTS-c? The research and its FDA status

MOTS-c is a small peptide encoded in mitochondrial DNA. What has been studied, what FDA has said, and what HHS's October 2026 draft policy would cover.

FDA peptide categories explained: Category 1, Category 2 and the 503A bulks list

FDA's Category 1 and 2, the 503A bulks list and HHS's October 2026 draft peptide policy: what each means for compounded peptides, and what none of them is.

How to get peptides legally: prescription vs research use only

Which peptides a licensed provider can prescribe, what HHS's 2026 draft policy would cover for six others, and why 'research use only' isn't for people.

Compounded tirzepatide vs semaglutide: how the two medicines differ

Compounded tirzepatide vs semaglutide, explained plainly: what each medicine acts on, how each is taken, and why a licensed provider decides which fits.